| Literature DB >> 30983138 |
Brianna Johnson-Rabbett1, Elizabeth R Seaquist1.
Abstract
Hypoglycemia is a frequent occurrence in patients with diabetes who are treated with insulin and insulin secretagogues. Hypoglycemia is the limiting factor that prevents patients from achieving the glycemic control known to reduce the microvascular complications of diabetes. Recurrent episodes of hypoglycemia can lead to impaired awareness of hypoglycemia where the first symptom of a low blood sugar is unconsciousness. The fear of hypoglycemia has a significant effect on the quality of life of patients and their families. In the acute setting, hypoglycemia can kill, and clinical trials have demonstrated that a single episode of severe hypoglycemia increases the risk of subsequent mortality and cardiovascular events. Clinicians must make efforts to recognize and prevent hypoglycemia in order to prevent the adverse events associated with this event. Patient education is central to these efforts. Recent developments in glucose monitoring and drug development have provided more approaches that can be used to reduce the risk of hypoglycemia in patients with diabetes.Entities:
Keywords: cardiovascular disease; diabetes; hypoglycemia; insulin; mortality; 低血糖; 心血管疾病; 死亡率; 糖尿病; 胰岛素
Mesh:
Substances:
Year: 2019 PMID: 30983138 DOI: 10.1111/1753-0407.12933
Source DB: PubMed Journal: J Diabetes ISSN: 1753-0407 Impact factor: 4.006